Advisory Committees

November 7, 2016: Risk Communication Advisory Committee Meeting Announcement

 

CenterDateTimeLocation
OCNovember 7, 20168:30 a.m. – 5:00 p.m.
 
Food and Drug Administation
10903 New Hampshire Ave.
Bldg. 31, Rm. 1503
Silver Spring, MD. 20993
 

Agenda

On November 7, 2016, the committee will discuss and make recommendations on FDA's draft Strategic Plan for Risk Communication and Health Literacy. The purpose of the Strategic Plan for Risk Communication and Health Literacy is to clarify how the Agency can communicate the benefits and risks of FDA-regulated products to target audiences more effectively, and so promote better informed decision making. The committee will also hear presentations on some of FDA's external communications and how these communications relate to the draft Strategic Plan for Risk Communication and Health Literacy.

FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting. Background material is available at: 2016 Meeting Materials, Risk Communication Advisory Committee.

Procedure

Information regarding special accommodations due to a disability, visitor parking, and transportation may be accessed at "Public Meetings on the FDA White Oak Campus" on the FDA website. Please note that visitors to the White Oak Campus must enter through Building 1.

A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's advisory committee web page and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.

Public Participation Information

Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.

  • Written submissions may be made to the contact person on or before November 1, 2016.
  • Oral presentations from the public will be scheduled between approximately 1:30 p.m. to 2:30 p.m.
  • Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 21, 2016. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session.
  • The contact person will notify interested persons regarding their request to speak by October 25, 2016.

Webcast Information

We plan to provide a free of charge, live webcast of the November 7, 2016 meeting of the Risk Communication Advisory Committee. While we are working to make webcasts available to the public for all advisory committee meetings held at the White Oak campus, there are instances where the webcast transmission is not successful; staff will work to re-establish the transmission as soon as possible. The webcast will be available at the following link: 2016 Meeting Materials, Risk Communication Advisory Committee.

Contact Information

Natasha Facey, Designated Federal Officer
10903 New Hampshire Avenue, Building 32, Room 3354
Phone: 301-796-5290
Fax: 301-847-3540
Email: RCAC@fda.hhs.gov

FDA Advisory Committee Information Line
1-800-741-8138 or 301-443-0572 in the Washington, D.C. area
Please call the information line for up-to-date information on this meeting

Persons attending FDA's advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets.

FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact Sheryl Clark at Sheryl.Clark@fda.hhs.gov or 240-402-5273 at least 7 days in advance of the meeting.

FDA is committed to the orderly conduct of its advisory committee meetings. Please visit procedures on public conduct during advisory committee meetings.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).

Page Last Updated: 03/29/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English